Journey Beyond Wealth LLC bought a new stake in iShares U.S. Medical Devices ETF (NYSEARCA:IHI – Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 11,669 shares of the company’s stock, valued at approximately $597,000. iShares U.S. Medical Devices ETF makes up about 0.5% of Journey Beyond Wealth LLC’s investment portfolio, making the stock its 21st largest holding.
A number of other hedge funds have also added to or reduced their stakes in IHI. Scarborough Advisors LLC bought a new stake in iShares U.S. Medical Devices ETF during the 1st quarter worth about $32,000. William Mack & Associates Inc. acquired a new position in shares of iShares U.S. Medical Devices ETF during the 3rd quarter worth about $32,000. RMG Wealth Management LLC acquired a new position in shares of iShares U.S. Medical Devices ETF during the 1st quarter worth about $35,000. Livelsberger Financial Advisory acquired a new position in shares of iShares U.S. Medical Devices ETF during the 3rd quarter worth about $37,000. Finally, Next Level Wealth Planning LLC bought a new position in shares of iShares U.S. Medical Devices ETF in the 3rd quarter valued at about $54,000.
iShares U.S. Medical Devices ETF Price Performance
Shares of NYSEARCA IHI opened at $57.59 on Monday. The business has a 50-day moving average of $53.26 and a 200-day moving average of $53.56. The stock has a market capitalization of $3.94 billion, a price-to-earnings ratio of 30.76 and a beta of 0.81. iShares U.S. Medical Devices ETF has a fifty-two week low of $47.37 and a fifty-two week high of $64.71.
iShares U.S. Medical Devices ETF Profile
The iShares U.S. Medical Devices ETF (IHI) is an exchange-traded fund that is based on the DJ US Select \u002F Medical Equipment index, a market-cap-weighted index of manufacturers and distributors of medical devices in the US. IHI was launched on May 1, 2006 and is managed by BlackRock.
Featured Stories
- Five stocks we like better than iShares U.S. Medical Devices ETF
- Lemonade’s Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?
- Anthropic’s S-1 Strengthens the Case for Broadcom’s AI Growth
- After the Midterms, Which of These 3 Defense ETFs Looks Strongest?
- The Ugly Truth Behind SoundHound’s Q3 Results
Receive News & Ratings for iShares U.S. Medical Devices ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares U.S. Medical Devices ETF and related companies with MarketBeat.com's FREE daily email newsletter.
